-+ 0.00%
-+ 0.00%
-+ 0.00%

Milestone Pharmaceuticals FY 2025 net loss widens 52% to USD 63.1 million, commercial expense rises 157% to USD 28.3 million

Reuters·03/20/2026 11:25:55

Please log in to view news